Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Villarino, Margarita E.
and
Mazurek, Gerald
2006.
Tuberculosis Contacts, Concerns, and Controls: What Matters for Healthcare Workers?.
Infection Control & Hospital Epidemiology,
Vol. 27,
Issue. 5,
p.
433.
Nardell, Edward A.
and
Wallis, Robert S.
2006.
Here Today—Gone Tomorrow: The Case for Transient Acute Tuberculosis Infection.
American Journal of Respiratory and Critical Care Medicine,
Vol. 174,
Issue. 7,
p.
734.
Hernandez, Claudia
Cetner, Aaron S.
Jordan, J. Edward
Puangsuvan, Somchin N.
and
Robinson, June K.
2008.
Tuberculosis in the age of biologic therapy.
Journal of the American Academy of Dermatology,
Vol. 59,
Issue. 3,
p.
363.
Fox, Benjamin D.
Kramer, Mordechai R.
Mor, Zohar
Preiss, Rachel
Rusanov, Victoria
Fuks, Leonardo
Peled, Nir
Haim, Ilanit
Raz, Meir
and
Shitrit, David
2009.
The QuantiFERON®-TB-GOLD Assay for Tuberculosis Screening in Healthcare Workers: A Cost-Comparison Analysis.
Lung,
Vol. 187,
Issue. 6,
p.
413.
Lancioni, Christina
Nyendak, Melissa
Kiguli, Sarah
Zalwango, Sarah
Mori, Tomi
Mayanja-Kizza, Harriet
Balyejusa, Stephen
Null, Megan
Baseke, Joy
Mulindwa, Deo
Byrd, Laura
Swarbrick, Gwendolyn
Scott, Christine
Johnson, Denise F.
Malone, LaShaunda
Mudido-Musoke, Philipa
Boom, W. Henry
Lewinsohn, David M.
and
Lewinsohn, Deborah A.
2012.
CD8+T Cells Provide an Immunologic Signature of Tuberculosis in Young Children.
American Journal of Respiratory and Critical Care Medicine,
Vol. 185,
Issue. 2,
p.
206.
Catanzaro, Antonino
and
Daley, Charles
2013.
A Summary of the Third Global Interferon-γ Release Assay Symposium.
Infection Control & Hospital Epidemiology,
Vol. 34,
Issue. 6,
p.
619.
Johnson, Denise F.
Malone, LaShaunda L.
Zalwango, Sarah
Mukisa Oketcho, Joy
Chervenak, Keith A.
Thiel, Bonnie
Mayanja-Kizza, Harriet
Stein, Catherine M.
Boom, W. Henry
Lancioni, Christina L.
and
Wilkinson, Katalin Andrea
2014.
Tuberculin Skin Test Reversion following Isoniazid Preventive Therapy Reflects Diversity of Immune Response to Primary Mycobacterium tuberculosis Infection.
PLoS ONE,
Vol. 9,
Issue. 5,
p.
e96613.
Monárrez-Espino, Joel
Enciso-Moreno, José Antonio
Laflamme, Lucie
and
Serrano, Carmen J
2014.
Serial QuantiFERON-TB Gold In-Tube assay and tuberculin skin test to diagnose latent tuberculosis in household Mexican contacts: conversion and reversion rates and associated factors using conventional and borderline zone definitions.
Memórias do Instituto Oswaldo Cruz,
Vol. 109,
Issue. 7,
p.
863.
Gold, Marielle C.
Napier, Ruth J.
and
Lewinsohn, David M.
2015.
MR1‐restricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobacterium tuberculosis.
Immunological Reviews,
Vol. 264,
Issue. 1,
p.
154.
Nardell, Edward A
2021.
Time to Revise Our Tuberculosis Infection–Latency–Disease Model in High-burden Settings.
Clinical Infectious Diseases,
Vol. 72,
Issue. 11,
p.
2016.
Diel, Roland
Breuer, Cornelia
Bös, Lena
Geerdes-Fenge, Hilte
Günther, Annette
Häcker, Brit
Hannemann, Jörg
Nienhaus, Albert
Priwitzer, Martin
Witte, Peter
and
Bauer, Torsten
2023.
Empfehlungen für die Umgebungsuntersuchungen bei Tuberkulose – Update 2023.
Pneumologie,
Vol. 77,
Issue. 09,
p.
607.
Diel, Roland
Breuer, Cornelia
Bös, Lena
Geerdes-Fenge, Hilte
Günther, Annette
Häcker, Brit
Hannemann, Jörg
Nienhaus, Albert
Priwitzer, Martin
Witte, Peter
and
Bauer, Torsten
2023.
Empfehlungen für die Umgebungsuntersuchungen bei Tuberkulose
– Update 2023.
Das Gesundheitswesen,
Vol. 85,
Issue. 11,
p.
1076.
Dale, Katie D.
Schwalb, Alvaro
Coussens, Anna K.
Gibney, Katherine B.
Abboud, Alison J.
Watts, Krista
and
Denholm, Justin T.
2024.
Overlooked, dismissed, and downplayed: reversion ofMycobacterium tuberculosisimmunoreactivity.
European Respiratory Review,
Vol. 33,
Issue. 173,
p.
240007.